1. Home
  2. BDSX vs CBUS Comparison

BDSX vs CBUS Comparison

Compare BDSX & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$15.28

Market Cap

107.5M

Sector

Health Care

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.44

Market Cap

121.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
CBUS
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
107.5M
121.1M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
BDSX
CBUS
Price
$15.28
$1.44
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$32.50
$9.00
AVG Volume (30 Days)
73.6K
541.9K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.33
EPS
N/A
N/A
Revenue
$88,499,000.00
$3,639,000.00
Revenue This Year
$25.26
$112.72
Revenue Next Year
$19.15
$83.18
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$1.09
52 Week High
$20.21
$4.19

Technical Indicators

Market Signals
Indicator
BDSX
CBUS
Relative Strength Index (RSI) 60.89 40.27
Support Level $12.77 $1.21
Resistance Level $16.26 $1.54
Average True Range (ATR) 1.22 0.12
MACD 0.61 0.06
Stochastic Oscillator 86.52 42.47

Price Performance

Historical Comparison
BDSX
CBUS

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: